Breast Cancer Research | Volume 11 Issue 1

Submit a manuscript Register Follow us on

Explore journal

Articles

	Volume 11 Issue 1
	Comment
	Editorial The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin Stuart J Schnitt Breast Cancer Research 2009, 11:101 (27 February 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Review
	Review Are we HER-ting for innovation in neoadjuvant breast cancer trial design? Natasa Snoj, Philippe L Bedard, Evandro de Azambuja, Fatima Cardoso, Martine Piccart Breast Cancer Research 2009, 11:201 (16 January 2009) Abstract \| Full text \| PDF \| PubMed
	Review Transforming growth factor-β in breast cancer: too much, too late Mary Barcellos-Hoff, Rosemary J Akhurst Breast Cancer Research 2009, 11:202 (26 February 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Report
	Correction Correction: Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1 Hans Neubauer, Susan E Clare, Wojciech Wozny, Gerhard P Schwall, Slobodan Poznanovic, Werner Stegmann, Ulrich Vogel, Karl Sotlar, Diethelm Wallwiener, Raffael Kurek, Tanja Fehm, Michael A Cahill Breast Cancer Research 2009, 11:401 (13 January 2009) Full text \| PDF
	Research
	Research article CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines Gwladys Zabouo, Anne-Marie Imbert, Jocelyne Jacquemier, Pascal Finetti, Thomas Moreau, Benjamin Esterni, Daniel Birnbaum, François Bertucci, Christian Chabannon Breast Cancer Research 2009, 11:R1 (5 January 2009) Abstract \| Full text \| PDF \| PubMed
	Research article Phosphoinositide 3-kinase targeting by the β galactoside binding protein cytokine negates akt gene expression and leads aggressive breast cancer cells to apoptotic death Valerie Wells, Livio Mallucci Breast Cancer Research 2009, 11:R2 (8 January 2009) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary The cytokine beta-galactosidase binding protein induces apoptosis in aggressive breast cancer cells and, due to its physiological nature, could be safely evaluated as a therapeutic agent in a clinical trial.
	Research article Novel multicellular organotypic models of normal and malignant breast: tools for dissecting the role of the microenvironment in breast cancer progression Deborah L Holliday, Kellie T Brouilette, Anja Markert, Linda A Gordon, J Louise Jones Breast Cancer Research 2009, 11:R3 (19 January 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| 1 comment
	Research article Do Asian breast cancer patients have poorer survival than their western counterparts? A comparison between Singapore and Stockholm Benita Tan, Gek Lim, Kamila Czene, Per Hall, Kee Chia Breast Cancer Research 2009, 11:R4 (24 January 2009) Abstract \| Full text \| PDF \| PubMed
	Research article Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypes Rhonda Hattar, Ori Maller, Shauntae McDaniel, Kirk C Hansen, Karla J Hedman, Traci R Lyons, Scott Lucia, R Storey Wilson, Pepper Schedin Breast Cancer Research 2009, 11:R5 (27 January 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary Treatment with tamoxifen induces changes in the mammary stroma which combined with those in the epithelium produce a microenvironment that inhibits tumor cell progression, suggests data from an in-vitro study.
	Research article Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer Günther Weber, Clara Chamorro, Fredrik Granath, Annelie Liljegren, Sami Zreika, Zuzana Saidak, Bengt Sandstedt, Samuel Rotstein, Romuald Mentaverri, Fabio Sánchez, Andor Pivarcsi, Mona Ståhle Breast Cancer Research 2009, 11:R6 (30 January 2009) Abstract \| Full text \| PDF \| PubMed
	Research article Gene expression profiling of the tumor microenvironment during breast cancer progression Xiao-Jun Ma, Sonika Dahiya, Elizabeth Richardson, Mark Erlander, Dennis C Sgroi Breast Cancer Research 2009, 11:R7 (2 February 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Research article A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history Encarna B Gómez García, Jan C Oosterwijk, Maarten Timmermans, Christi J van Asperen, Frans BL Hogervorst, Nicoline Hoogerbrugge, Rogier Oldenburg, Senno Verhoef, Charlotte J Dommering, Margreet GEM Ausems, Theo AM van Os, Annemarie H van der Hout, Marjolijn Ligtenberg, Ans van den Ouweland, Rob B van der Luijt, Juul T Wijnen, Jan JP Gille, Patrick J Lindsey, Peter Devilee, Marinus J Blok, Maaike PG Vreeswijk Breast Cancer Research 2009, 11:R8 (6 February 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Research article Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry Jason A Zell, Walter Y Tsang, Thomas H Taylor, Rita S Mehta, Hoda Anton-Culver Breast Cancer Research 2009, 11:R9 (19 February 2009) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary Although associated with inflammatory breast cancer, HER2 positive status is not an adverse prognostic factor for this tumour type and does not explain low patient survival rates.
	Research article Association between breast cancer susceptibility loci and mammographic density: the Multiethnic Cohort Christy G Woolcott, Gertraud Maskarinec, Christopher A Haiman, Martijn Verheus, Ian S Pagano, Loïc Le Marchand, Brian E Henderson, Laurence N Kolonel Breast Cancer Research 2009, 11:R10 (21 February 2009) Abstract \| Full text \| PDF \| PubMed
	Research article Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors Thomas Frogne, Anne-Vibeke Laenkholm, Maria B Lyng, Katrine Henriksen, Anne E Lykkesfeldt Breast Cancer Research 2009, 11:R11 (24 February 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Research article Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells Satoshi Nakayama, Yasuhiro Torikoshi, Takeshi Takahashi, Tomokazu Yoshida, Tamotsu Sudo, Tomoko Matsushima, Yuko Kawasaki, Aya Katayama, Keigo Gohda, Gabriel N Hortobagyi, Shinzaburo Noguchi, Toshiyuki Sakai, Hideki Ishihara, Naoto T Ueno Breast Cancer Research 2009, 11:R12 (24 February 2009) Abstract \| Full text \| PDF \| PubMed
	Research article Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion Tim Eiseler, Heike Döppler, Irene K Yan, Steve Goodison, Peter Storz Breast Cancer Research 2009, 11:R13 (25 February 2009) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary Protein kinase D1 is identified as a marker for invasive breast cancer, while loss of PKD1 expression may increase the malignant potential of breast cancer cells, suggesting re-expression of PKD1 as a possible therapeutic strategy.
	Research article Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer Stella Tommasi, Deborah L Karm, Xiwei Wu, Yun Yen, Gerd P Pfeifer Breast Cancer Research 2009, 11:R14 (27 February 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central

	Volume 11 Issue 1
	Comment
	Editorial The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin Stuart J Schnitt Breast Cancer Research 2009, 11:101 (27 February 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Review
	Review Are we HER-ting for innovation in neoadjuvant breast cancer trial design? Natasa Snoj, Philippe L Bedard, Evandro de Azambuja, Fatima Cardoso, Martine Piccart Breast Cancer Research 2009, 11:201 (16 January 2009) Abstract \| Full text \| PDF \| PubMed
	Review Transforming growth factor-β in breast cancer: too much, too late Mary Barcellos-Hoff, Rosemary J Akhurst Breast Cancer Research 2009, 11:202 (26 February 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Report
	Correction Correction: Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1 Hans Neubauer, Susan E Clare, Wojciech Wozny, Gerhard P Schwall, Slobodan Poznanovic, Werner Stegmann, Ulrich Vogel, Karl Sotlar, Diethelm Wallwiener, Raffael Kurek, Tanja Fehm, Michael A Cahill Breast Cancer Research 2009, 11:401 (13 January 2009) Full text \| PDF
	Research
	Research article CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines Gwladys Zabouo, Anne-Marie Imbert, Jocelyne Jacquemier, Pascal Finetti, Thomas Moreau, Benjamin Esterni, Daniel Birnbaum, François Bertucci, Christian Chabannon Breast Cancer Research 2009, 11:R1 (5 January 2009) Abstract \| Full text \| PDF \| PubMed
	Research article Phosphoinositide 3-kinase targeting by the β galactoside binding protein cytokine negates akt gene expression and leads aggressive breast cancer cells to apoptotic death Valerie Wells, Livio Mallucci Breast Cancer Research 2009, 11:R2 (8 January 2009) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary The cytokine beta-galactosidase binding protein induces apoptosis in aggressive breast cancer cells and, due to its physiological nature, could be safely evaluated as a therapeutic agent in a clinical trial.
	Research article Novel multicellular organotypic models of normal and malignant breast: tools for dissecting the role of the microenvironment in breast cancer progression Deborah L Holliday, Kellie T Brouilette, Anja Markert, Linda A Gordon, J Louise Jones Breast Cancer Research 2009, 11:R3 (19 January 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| 1 comment
	Research article Do Asian breast cancer patients have poorer survival than their western counterparts? A comparison between Singapore and Stockholm Benita Tan, Gek Lim, Kamila Czene, Per Hall, Kee Chia Breast Cancer Research 2009, 11:R4 (24 January 2009) Abstract \| Full text \| PDF \| PubMed
	Research article Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypes Rhonda Hattar, Ori Maller, Shauntae McDaniel, Kirk C Hansen, Karla J Hedman, Traci R Lyons, Scott Lucia, R Storey Wilson, Pepper Schedin Breast Cancer Research 2009, 11:R5 (27 January 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary Treatment with tamoxifen induces changes in the mammary stroma which combined with those in the epithelium produce a microenvironment that inhibits tumor cell progression, suggests data from an in-vitro study.
	Research article Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer Günther Weber, Clara Chamorro, Fredrik Granath, Annelie Liljegren, Sami Zreika, Zuzana Saidak, Bengt Sandstedt, Samuel Rotstein, Romuald Mentaverri, Fabio Sánchez, Andor Pivarcsi, Mona Ståhle Breast Cancer Research 2009, 11:R6 (30 January 2009) Abstract \| Full text \| PDF \| PubMed
	Research article Gene expression profiling of the tumor microenvironment during breast cancer progression Xiao-Jun Ma, Sonika Dahiya, Elizabeth Richardson, Mark Erlander, Dennis C Sgroi Breast Cancer Research 2009, 11:R7 (2 February 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Research article A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history Encarna B Gómez García, Jan C Oosterwijk, Maarten Timmermans, Christi J van Asperen, Frans BL Hogervorst, Nicoline Hoogerbrugge, Rogier Oldenburg, Senno Verhoef, Charlotte J Dommering, Margreet GEM Ausems, Theo AM van Os, Annemarie H van der Hout, Marjolijn Ligtenberg, Ans van den Ouweland, Rob B van der Luijt, Juul T Wijnen, Jan JP Gille, Patrick J Lindsey, Peter Devilee, Marinus J Blok, Maaike PG Vreeswijk Breast Cancer Research 2009, 11:R8 (6 February 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Research article Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry Jason A Zell, Walter Y Tsang, Thomas H Taylor, Rita S Mehta, Hoda Anton-Culver Breast Cancer Research 2009, 11:R9 (19 February 2009) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary Although associated with inflammatory breast cancer, HER2 positive status is not an adverse prognostic factor for this tumour type and does not explain low patient survival rates.
	Research article Association between breast cancer susceptibility loci and mammographic density: the Multiethnic Cohort Christy G Woolcott, Gertraud Maskarinec, Christopher A Haiman, Martijn Verheus, Ian S Pagano, Loïc Le Marchand, Brian E Henderson, Laurence N Kolonel Breast Cancer Research 2009, 11:R10 (21 February 2009) Abstract \| Full text \| PDF \| PubMed
	Research article Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors Thomas Frogne, Anne-Vibeke Laenkholm, Maria B Lyng, Katrine Henriksen, Anne E Lykkesfeldt Breast Cancer Research 2009, 11:R11 (24 February 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Research article Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells Satoshi Nakayama, Yasuhiro Torikoshi, Takeshi Takahashi, Tomokazu Yoshida, Tamotsu Sudo, Tomoko Matsushima, Yuko Kawasaki, Aya Katayama, Keigo Gohda, Gabriel N Hortobagyi, Shinzaburo Noguchi, Toshiyuki Sakai, Hideki Ishihara, Naoto T Ueno Breast Cancer Research 2009, 11:R12 (24 February 2009) Abstract \| Full text \| PDF \| PubMed
	Research article Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion Tim Eiseler, Heike Döppler, Irene K Yan, Steve Goodison, Peter Storz Breast Cancer Research 2009, 11:R13 (25 February 2009) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary Protein kinase D1 is identified as a marker for invasive breast cancer, while loss of PKD1 expression may increase the malignant potential of breast cancer cells, suggesting re-expression of PKD1 as a possible therapeutic strategy.
	Research article Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer Stella Tommasi, Deborah L Karm, Xiwei Wu, Yun Yen, Gerd P Pfeifer Breast Cancer Research 2009, 11:R14 (27 February 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central

Explore journal

Articles

Volume 11 Issue 1

Comment

Review

Report

Research